Hospira Gemcitabine Injection (38 mg/mL) 2 g/52.6 mL (US)

Land: Australia

Språk: engelsk

Kilde: Department of Health (Therapeutic Goods Administration)

Aktiv ingrediens:

gemcitabine hydrochloride, Quantity: 43.27 mg/mL

Tilgjengelig fra:

Hospira Australia Pty Ltd

INN (International Name):

Gemcitabine hydrochloride

Legemiddelform:

Injection, solution

Sammensetning:

Excipient Ingredients: sodium hydroxide; hydrochloric acid; water for injections

Administreringsrute:

Intravenous Infusion

Enheter i pakken:

1 x 52.6 mL pack

Klasse:

Medicine Listed (Export Only)

Resept typen:

(S1) This Schedule is intentionally blank

Indikasjoner:

Ovarian cancer, breast cancer, non small cell lung cancer, pancreatic cancer

Produkt oppsummering:

Visual Identification: A clear, colourless or light straw coloured solution practically free from visible particles; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 18 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Child resistant closure and restricted flow insert

Autorisasjon status:

Licence status A

Autorisasjon dato:

2011-11-04